Pic

PAVmed Inc.

$PAVM
$0.35
Капитализция: $100.2M
Показать больше информации о компании

О компании

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome and EsoCheck, an esophageal показать больше
cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE) and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE PortIO, an implantable intraosseous vascular access device NextFlo, a disposable infusion platform technology Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics NextVent single-use ventilators FlexMO medical circulatory support cannulas Veris cardiac monitors DisappEAR resorbable pediatric ear tubes Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE) and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE PortIO, an implantable intraosseous vascular access device NextFlo, a disposable infusion platform technology Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics NextVent single-use ventilators FlexMO medical circulatory support cannulas Veris cardiac monitors DisappEAR resorbable pediatric ear tubes Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Перевод автоматический

показать меньше

Отчетность

03.11.2021, 23:08 EPS за 3 квартал составил ХХ, консенсус YY

04.08.2021, 23:12 Прибыль на акцию за 2 квартал XX, консенсус-прогноз YY
Квартальная отчетность будет доступна после Регистрации

Прогнозы аналитиков

Аналитик Аарон Кесслер поддерживает с сильной покупкой и снижает целевую цену со xxx до yyy долларов.

25.10.2021, 16:02 Аналитик Berenberg Сунил Райгопал инициирует освещение на GoDaddy с рейтингом «Покупать» и объявляет целевую цену в xxx долларов.
Прогнозы аналитиков будут доступны после Регистрации

Все новости компании PAVmed

Новости переведены автоматически

Остальные 14 новостей будут доступны после Регистрации

Попробуйте все возможности сервиса Tradesense

Моментальные уведомления об измемении цен акций
Новости с официальных сайтов компаний
Отчётности компаний
События с FDA, SEC
Прогнозы аналитиков и банков
Регистрация в сервисе
Tradesense доступен на мобильных платформах